CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 226,000 shares at an average $0.67 ($151,946)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 510,000 shares at an average $0.67 ($344,133)
- 4 Open-market buy Director bought 140,000 shares at an average $0.80 ($111,806)
- 4 Open-market buy Director bought 288,000 shares at an average $0.80 ($231,564)
- 4 Open-market buy Director bought 312,000 shares at an average $0.88 ($274,486)
- 4 Open-market buy Director bought 455,000 shares at an average $1.00 ($452,768)
- 4 Open-market buy Director bought 645,000 shares at an average $1.00 ($642,931)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 6,371 shares at $1.57 ($10,002)
- 4 Open-market buy Chief Accounting Officer bought 955 shares at $1.57 ($1,499)
- 4 Open-market buy Chief Commercial Officer bought 1,093 shares at $1.57 ($1,716)
Page 9 of 28 · 552 filings